Gabriel Guízar-Sahagún

Dr. Gabriel Guízar-Sahagún


Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 1990 in Archives of Neurology
Verified
Journal Article
Closed access
PDF file
IMIgnacio Madrazo
Ignacio Madrazo
RFRebecca Franco-Bourland
Rebecca Franco-Bourland
FOFeggy Ostrosky-Solis
Feggy Ostrosky-Solis
MAMaricarmen Aguilera
Maricarmen Aguilera
CCCarlos Cuevas
Carlos Cuevas
GGGabriel Guízar-Sahagún
Gabriel Guízar-Sahagún
• Fetal ventral mesencephalon and fetal adrenal tissue grafted to the caudate nucleus of four and three parkinsonian patients, respectively, have been shown to be an alternative treatment for the amelioration of the signs of the disease. The ventral mesencephalon patients had a significant amelioration of rigidity, bradykinesia, postural imbalance, gait disturbance, and facial expression. Three of these four patients have returned to work. The fatal adrenal group only showed amelioration of rigidity and bradykinesia. Though these patients are now able to perform their basic daily living activities, and one of them has renewed her household tasks, the other two have not yet been able to return to work. The differences observed between the ventral mesencephalon- and the fetal adrenal-transplanted patients may be related to the heterogeneity of their disease and/or the type of graft implanted. However encouraging our results may be, this experimental procedure obviously requires further studies, and should not be practiced outside of highly qualified clinical research centers.

26 June 2009 in Child's Nervous System
Verified
Journal Article
Closed access
PDF file
JPJefferson V. Proaño
Jefferson V. Proaño
JTJaime Torres-Corzo
Jaime Torres-Corzo
RVRoberto Rodríguez-Della Vecchia
Roberto Rodríguez-Della Vecchia
GGGabriel Guízar-Sahagún
Gabriel Guízar-Sahagún
LRLeonardo Rangel-Castilla
Leonardo Rangel-Castilla

1 April 2004 in Current Medicinal Chemistry-Cardiovascular & Hematological Agents
Verified
Journal Article
Closed access
PDF file
GBGuadalupe Bravo
Guadalupe Bravo
GGGabriel Guízar-Sahagún
Gabriel Guízar-Sahagún
Antonio IbarraAntonio Ibarra
Antonio Ibarra
David CenturiónDavid Centurión
David Centurión
CVCarlos M. Villalon
Carlos M. Villalon
The recent developments in the management of spinal cord injury (SCI) have led to a reduction in mortality and in the consequences, resulting from incomplete spinal cord damage in those who survive. In this respect, it is noteworthy that SCI not only results in paraplegia or tetraplegia, but also in systemic, cardiovascular and metabolic alterations secondary to autonomic dysfunction. After SCI there is a decrease in sympathetic discharge and an increase in parasympathetic drive, resulting in profound changes in arterial blood pressure and heart rate. When SCI is induced in experimental animals, an immediate hypotension occurs (acute phase) which has been attributed to an autonomic imbalance involving a predominance of parasympathetic activity. Subsequently, an episodic hypertension may develop (chronic phase) as a part of a condition denominated autonomic dysreflexia. This hypertension is caused by afferent stimulation below the level of injury and can be so severe that sometimes may lead to cerebral haemorrhage, seizures, and death. In the light of the above lines of evidence, experimental SCI may provide an ideal model to study the nature of cardiovascular mechanisms following traumatic injury. Thus, the present review will deal with an update of the possible cardiovascular complications associated to SCI (including spinal shock, autonomic dysreflexia, deep venous thrombosis, and risk for coronary heart disease). This will be discussed within the context of the development of drugs with potential therapeutic usefulness in the acute and chronic stages of SCI.

1 April 1999 in Neuroscience Letters
Verified
Journal Article
Closed access
ADAraceli Diaz-Ruiz
Araceli Diaz-Ruiz
CRCamilo Rios
Camilo Rios
IDIvonne Duarte
Ivonne Duarte
DCDolores Correa
Dolores Correa
GGGabriel Guízar-Sahagún
Gabriel Guízar-Sahagún
AIAntonio Ibarra
Antonio Ibarra

31 March 1994 in Surgical Neurology
Verified
Journal Article
Closed access
GGGabriel Guízar-Sahagún
Gabriel Guízar-Sahagún
IGIsrael Grijalva
Israel Grijalva
IMIgnacio Madrazo
Ignacio Madrazo
RFRebecca Franco-Bourland
Rebecca Franco-Bourland
HSHermelinda Salgado
Hermelinda Salgado
AZArmando Zepeda
Armando Zepeda

1 July 2003 in Brain Research
Verified
Journal Article
Closed access
Antonio IbarraAntonio Ibarra
Antonio Ibarra
DCDolores Correa
Dolores Correa
KWKaethe Willms
Kaethe Willms
MMMarie Therese Merchant
Marie Therese Merchant
GGGabriel Guízar-Sahagún
Gabriel Guízar-Sahagún
IMIgnacio Madrazo
Ignacio Madrazo